Introduction Semaglutide, a medication that has taken the healthcare world by storm, is revolutionizing the treatment landscape for individuals with type 2 diabetes and obesity. Initially developed as a treatment for diabetes, Semaglutide belongs to the GLP-1 (glucagon-like peptide-1) receptor agonist class of drugs. By mimicking the natural hormone GLP-1, https://raymondeyria.cosmicwiki.com/1118732/semaglutide_a_revolutionary_treatment_for_diabetes_obesity_and_heart_health